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The impact of HIV on maternal mortality and more broadly on the health of women, remains poorly documented and understood.
Two recent reports attempt to address the conceptual and methodological challenges that arise in estimating HIV-related maternal
mortality and trends. This paper presents and compares the methods and discusses how they affect estimates at global and regional
levels. Country examples of likely patterns of mortality among women of reproductive age are provided to illustrate the critical
interactions between HIV and complications of pregnancy in high-HIV-burden countries. The implications for collaboration
between HIV and reproductive health programmes are discussed, in support of accelerated action to reach the Millennium
Development Goals and improve the health of women.
1. Introduction
While recent reports indicate declining trends in maternal
mortality [1, 2], at the current rate of progress, most coun-
tries remain unlikely to reach the Millennium Development
Goal 5 and its target of reducing the maternal mortality ratio
(MMR) by 75% between 1990 and 2015. The adverse effect
of HIV on women’s health in sub-Saharan Africa appears to
be an important reason for poor progress [1, 3].
The contribution of HIV to maternal mortality has been
recognized for over a decade [4, 5], but it remains poorly
documented and understood. The number and proportion
of maternal deaths associated with HIV have been difficult to
determine with precision because of various conceptual and
measurement challenges [1, 2]. This information is critical
to plan services for women in need, including HIV-infected
pregnant women.
This paper aims to enhance the understanding of the
methods used to estimate HIV-associated maternal deaths
and how they affect global, regional, and country estimates.
Country examples of likely patterns of mortality among
women of reproductive age are provided to illustrate the
critical interactions between HIV and maternal mortality in
high-HIV-burden countries.
2. Methods for Estimating HIV-Associated
Maternal Deaths
2.1. Definitions. In the International Statistical Classification
of Diseases and Related Health Problems, Tenth Revision,
1992 (ICD-10), WHO defines maternal death as the death of
a woman while pregnant or within 42 days of termination
of pregnancy, irrespective of the duration and site of the
pregnancy, from any cause related to or aggravated by
the pregnancy or its management but not from accidental
or incidental causes [6]. Maternal deaths are either direct
obstetric deaths resulting from obstetric complications of
the pregnant state (pregnancy, delivery, and postpartum),
from interventions, omissions, incorrect treatment, or from
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a chain of events resulting from any of the above, or
indirect deaths resulting from previous existing disease or
disease that developed during pregnancy, such as anaemia
and malaria, which was aggravated by physiological effects
of pregnancy. In some instances, deaths during pregnancy
or the postpartum period might be due to causes that are
incidental to pregnancy, such as accidents and violence.
These are defined in ICD as pregnancy-related deaths, but are
not included as part of maternal deaths. Pregnancy-related
deaths comprise maternal deaths due to direct and indirect
causes and also deaths due to accidental or incidental events
that occur when a woman is pregnant.
Some of the deaths of pregnant women with HIV are
incidental deaths due to an AIDS-defining condition, with-
out any obvious association with pregnancy. These deaths
are therefore classified as pregnancy-related deaths, but not
maternal deaths. In practice, the distinction between in-
cidental and indirect causes of death is difficult to make,
especially in the case of HIV. The effect of pregnancy on HIV
disease progression is uncertain [7–9], but HIV would not
likely be an indirect cause of death except in advanced stages
of the disease. It is also not clear to what extent HIV infection
has an effect on the maternal outcomes of pregnancy [7, 8].
However, there is some evidence that HIV can aggravate
obstetric conditions that can lead to death, such as sepsis,
haemorrhage, and septic abortion [9, 10].
Figure 1 is a graphical representation of the intersection
of HIV deaths and maternal deaths among all deaths of
women of reproductive age (15–49 years). In this paper, we
use the term “HIV-associated maternal death” to describe
the death of a pregnant woman with HIV in which the HIV
infection was present at the time of a death from direct
obstetric causes or else was an indirect cause of maternal
death. The figure shows that HIV-associated maternal deaths
are a subset of what we call “pregnancy-related HIV deaths,”
which include all deaths in HIV-positive women that take
place during pregnancy, childbirth, and 42 days postpartum.
These include deaths from HIV disease that were incidental
to the pregnancy. This figure does not attempt to show the
relative distribution of deaths in the various categories. For
orders of magnitude, it is useful to recall here that HIV/AIDS
and complications of pregnancy and childbirth are the two
leading causes of death in young adult women globally,
accounting for 19% and 15% of all deaths in women aged
15–44 years, respectively [11].
2.2. Measurement Challenges. In the real world, identifying
maternal deaths and determining their causes, in order
to differentiate deaths due to direct or indirect causes, or
to incidental causes, poses many challenges. Most devel-
oping countries do not have civil registration systems to
record the death of a woman of reproductive age, and
identification of maternal deaths usually requires special
methods of investigation, such as household surveys. In
addition, there are well-documented problems with regard to
the identification of cause of death in general and maternal
death in particular, which are exacerbated in the context
of HIV [12–14]. Ideally, HIV-associated maternal deaths
should be counted using the ICD-10 classification system,
along with other causes of maternal deaths—direct and
indirect. In practice, this is challenging, due to insufficient
or inaccurate information on the circumstances of death and
limited capacities to correctly use standards to assign and
code causes of death. In particular, information about the
woman’s pregnancy status or HIV status is often missing or
withheld. Even when deaths are medically certified, applying
the ICD rules when deaths are associated with multiple
comorbidities is not straightforward [2, 10]. With ICD-
10, WHO recommends the inclusion of a checkbox on the
death certificate for recording a woman’s pregnancy status
at the time of death, but this has not been implemented in
many countries, and therefore some AIDS deaths in preg-
nant women are not identified as pregnancy-related. The
overall result is that most countries report incomplete and
inaccurate data on numbers and causes of maternal and
pregnancy-related deaths, and the precise contribution of
HIV is poorly documented.
2.3. Methods of Estimating HIV-Associated Maternal Deaths.
In the run-up to the 2015 deadline to achieve the Millennium
Development Goals, increased efforts are being made to track
progress in reducing maternal mortality. In 2010, two major
reports provided estimates of maternal mortality trends at
global, regional, and country levels [1, 2]. Maternal mortality
estimates were based on data collected through a variety
of methods, including civil registration systems, household
surveys, special studies, censuses, and verbal autopsies [2].
Different statistical modeling approaches were used to es-
timate the contribution of HIV to maternal mortality.
Hogan and colleagues, at the Institute for Health Metrics
and Evaluation (IHME) and other academic institutions,
estimated levels and trends in maternal mortality for 181
countries between 1980 and 2008 and assessed the impact of
HIV on these estimates. Details on the IHME methodological
approach can be found in the published report [1], webannex
[15], and model output data published on the IHME website
(http://www.who.int/gho/maternal health/mortality/mater-
nal/en/index.html). In summary, IHME’s multivariate model
included HIV prevalence as one of several covariates to
estimate total maternal deaths, including what the authors
call “HIV-related maternal deaths.” To distinguish the HIV-
related deaths among the total number of maternal deaths,
IHME conducted a counterfactual analysis that explored the
effect on maternal mortality of reducing HIV prevalence to
zero, by setting the HIV covariates of the estimated model
to zero values. The difference between the two outputs
produced the number of HIV-related maternal deaths. The
primary source of data used in many countries was surveys or
censuses, which do not exclude incidental deaths in pregnant
women. Therefore, the numbers reported by IHME in those
countries relate to our definition of pregnancy-related HIV
death, including both HIV-associated maternal deaths and
HIV deaths that are incidental to the pregnancy. Hogan
and colleagues indicate that this approach would tend to
bias the maternal mortality estimates upward, but note that
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Figure 1: The intersecting epidemics of HIV and maternal mortality.
there is no evidence-based analytical strategy to identify the
proportion of pregnancy-related deaths that are incidental.
The UN-affiliated Maternal Mortality Estimation Inter-
Agency Group (MMEIG), together with academics from the
University of California at Berkeley, developed estimates of
indirect maternal deaths due to HIV as part of a larger
effort to estimate country, regional, and global maternal
mortality levels and trends between 1990 and 2008 [2, 16].
The interagency group also took available data on total
deaths in women of reproductive age as the starting point,
but applied different statistical models and assumptions to
generate estimates of maternal deaths. In the first instance,
only maternal, non-HIV-related deaths were computed, by
subtracting the fraction of estimated HIV deaths in the
pregnancy-related period (which corresponds to our defi-
nition of pregnancy-related HIV deaths). Then the number
of indirect maternal deaths due to HIV was computed and
added back to obtain the total number of estimated maternal
deaths.
The steps in this process were as follows (see also [2], data
files available on the WHO web site http://www.who.int/gho/
maternal health/mortality/maternal/en/index.html). First, a
statistical model estimated the fraction of HIV deaths in
women of reproductive age occurring during pregnancy or
within 42 days of termination of pregnancy. The calculations
required assumptions about the relative risk of dying from
HIV of a pregnant versus a nonpregnant woman (reflecting
both the decreased fertility of HIV-positive women and the
increased mortality risk of HIV-positive pregnant women).
This latter parameter was developed through a combination
of expert opinion and tests of model fitness to reach a value
of 0.4, which was applied to all countries. These deaths
were removed from the computation of maternal deaths
due to direct obstetric causes or to indirect causes other
than HIV. Then a constant fraction of these deaths, counted
as indirect maternal deaths, was added back to calculate
total maternal deaths. For the estimation of these HIV-
related indirect maternal deaths, it was assumed that half
of the total pregnancy-related deaths among HIV-infected
women were indirect maternal deaths, the other half being
incidental to the pregnancy. This value was chosen to
minimize distribution errors given the scarcity of appropriate
data for estimating correct proportion of HIV deaths that are
incidental (which can vary over time and place).
3. Results Based on the Different Methods
3.1. Worldwide HIV-Associated Maternal Deaths. The inter-
agency group estimated 21,000 HIV-associated maternal
deaths (uncertainty interval 15,341–29,120), or 6% of the
worldwide total of 358,000 maternal deaths in 2008. For
the same year, the IHME calculated that 61,400 fewer
maternal deaths (18%) would have occurred in the absence
of HIV (uncertainty interval 58,200–66,400), of an estimated
total of 342,900 maternal deaths. As noted above, the
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interagency model computed pregnancy-related HIV deaths
and assumed that half of those were indirect maternal
deaths. Direct maternal deaths in which HIV was present,
and possibly a contributing factor, were not counted. The
other model computed primarily pregnancy-related HIV
deaths. Should the IHME model have used the interagency
assumption about the proportion of pregnancy-related HIV
deaths that are truly maternal, their estimated numbers of
HIV-associated maternal death and total number of maternal
deaths would have been reduced accordingly.
3.2. Regional Variation in HIV-Associated Maternal Deaths.
Both models show that the vast majority of HIV-associated
maternal deaths occur in sub-Saharan Africa (86% in the
interagency model and 92% in the IHME model) (Table 1).
As a fraction of all maternal deaths, HIV-associated maternal
deaths are also highest in the sub-Saharan region (9% under
the interagency model and 32% in the IHME model). In
other regions, HIV-associated maternal deaths account for
6% or less of all maternal deaths.
3.3. HIV-Associated Maternal Deaths by Country. The rank-
ing of countries with the highest number of HIV-related
maternal deaths varies substantially by model (Table 2).
Nigeria is consistently ranked first, although the estimated
number of deaths per year ranges widely, between 2,472
for the interagency model and 10,422 for the IHME model.
Six countries make the top ten under both model es-
timates—Kenya, Malawi, Mozambique, Nigeria, Tanzania,
and Uganda. However, their ranking differs under each
model. Only one country outside sub-Saharan Africa, India,
is in the top ten.
The countries with the highest fraction of HIV-related
maternal deaths are shown in Table 3. The list is dominated
by countries in Southern Africa that have been hardest hit
by the HIV epidemic. In many of these countries, HIV-as-
sociated maternal deaths represent a substantial proportion
of total maternal deaths. Both the interagency and IHME
approaches estimate the fraction at greater than 70% for
Botswana and Swaziland and over one-third for all countries
in the top ten.
3.4. Relative Impact of HIV on Pregnancy-Related and Ma-
ternal Mortality at Country Level. Figure 2 shows the sub-
stantial impact HIV has on the health of women in Zambia,
a high-prevalence country. Based on the interagency group
estimates, 21,532 or two-thirds of the 32,510 deaths of
women of reproductive age in 2008 can be attributed to
HIV. Of the total of 3,673 pregnancy-related deaths, 2,551
are maternal deaths. Of maternal deaths, 943 (37%) are
estimated to be HIV associated. Another 943 women are esti-
mated to die from incidental HIV deaths during pregnancy.
Figure 3 shows the pattern in the Democratic Republic
of Congo. In that country, a smaller proportion of deaths
among women of reproductive age are reported to be as-
sociated with HIV, and a larger proportion of deaths are
due to complications of pregnancy and childbirth. The op-
posite would seem to be the case in Zimbabwe, where the
overwhelming majority of deaths among women of repro-
ductive age are associated with HIV, as shown in Figure 4.
Similar charts can be produced to support more detailed
assessments of the situation in other affected countries.
4. Comparison of Methods and Results
We examined some of the challenges in defining and count-
ing HIV-associated maternal deaths and reviewed two recent
methodological approaches for their estimation. (This paper
does not attempt to explain why the interagency and IHME
estimates for maternal deaths might differ. For further dis-
cussion, see Section 3.6 of [2].) Both approaches address the
well-known conceptual and practical difficulties in assessing
a pregnancy-related death in the presence of HIV. They
use statistical models to estimate the impact of HIV on
levels and trends of maternal mortality, combining robust
data sources with assumptions regarding key parameters
about which little information exists. The interagency group
estimates of indirect maternal deaths due to HIV rest on
assumptions about the relative risk of HIV mortality in
pregnant versus nonpregnant women and the proportion
of pregnancy-related HIV mortality that can be considered
maternal. IHME uses a counterfactual method that compares
results with and without the HIV epidemic.
There are major differences in the way each model iden-
tifies pregnancy-related HIV deaths and examines the asso-
ciation of HIV with maternal deaths. The IHME model
produces somewhat higher results, with the number of HIV-
associated maternal deaths (61,400) about three times higher
than the interagency estimates. In part because the IHME
model has a lower overall number of maternal deaths, the
fraction of maternal deaths associated with HIV is sub-
stantially higher when compared to the interagency model.
Regional estimates of both numbers and affected fraction
follow a similar pattern between models. At the country level,
the models produce similar rankings in terms of the most
affected countries, although the estimated numbers and af-
fected fractions vary.
These comparisons should be made with caution, partly
because of the different model approaches and in how the
results are presented. The interagency estimate distinguishes
between incidental pregnancy-related HIV deaths and indi-
rect HIV-related maternal deaths, to keep strictly to the
ICD-10 definition of maternal death, without being able to
fully delineate the differences between the two. The IHME
model notes that the evidence to identify the proportion of
pregnancy-related deaths that are incidental is scant, and its
estimates are based on total numbers of pregnancy-related
deaths in which HIV was present, while recognizing that this
strategy biases the estimates upwards.
Despite these differences, estimates using the different
methods clearly reinforce that the HIV epidemic is having a
profound influence on maternal mortality and, more broad-
ly, pregnancy-related mortality. Worldwide estimates of the
fraction of maternal deaths due to HIV range between 6
and 18%, with the majority of HIV-associated maternal
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Table 1: HIV-associated maternal deaths by region, 2008, by model.
MDG region
Number of HIV-associated maternal deaths Proportion of all maternal deaths
Interagency IHME Interagency IHME
World total 21,000 61,436 5.8% 17.9%
Developed regions 90 45 5.6% 3.4%
CIS countries 70 35 4.7% 2.6%
Developing regions 21,000 61,356 5.8% 18.0%
Africa 18,000 56,446 8.9% 31.5%
Northern Africa 10 28 0.3% 1.2%
Sub-Saharan Africa 18,000 56,418 9.0% 31.9%
Asia 1,700 4,358 1.2% 2.9%
Eastern Asia 80 42 1.0% 0.5%
South Asia 1,300 3,632 1.2% 3.0%
South-Eastern Asia 310 682 1.7% 3.9%
Western Asia — 2 0.0% 0.0%
Latin America and the Caribbean 480 510 5.2% 6.4%
Oceania 10 42 1.1% 5.8%
Table 2: 10 Countries with the highest number of HIV-associated maternal deaths, 2008, by model.
Interagency IHME
Ranking Country #HIV-associated maternal deaths Country #HIV-associated maternal deaths
1 Nigeria 2472 Nigeria 10422
2 South Africa 1920 Malawi 4689
3 Zimbabwe 1574 Ethiopia 3971
4 Tanzania 1552 Tanzania 3941
5 Uganda 1512 India 3531
6 India 1264 Mozambique 3448
7 Mozambique 1217 Kenya 3006
8 Kenya 1100 Côte d’Ivoire 2871
9 Malawi 961 Uganda 2611
10 Ethiopia 948 Zambia 2403








1 Botswana 78% Botswana 84%
2 Swaziland 75% Swaziland 84%
3 Lesotho 59% Lesotho 83%
4 Zimbabwe 53% Zimbabwe 82%
5 Namibia 50% South Africa 78%
6 South Africa 43% Zambia 73%
7 Zambia 37% Namibia 73%
8 Belize 35% Malawi 69%
9 Malawi 32% Mozambique 66%
10 Trinidad and Tobago 28% Uganda 51%
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Figure 2: Intersection of HIV and maternal mortality in Zambia, 2008. Source: http://www.who.int/gho/maternal health/
mortality/maternal/en/index.html.
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Figure 3: Intersection of HIV and maternal mortality in DRC, 2008. Source: http://www.who.int/gho/maternal health/mortality/
maternal/en/index.html.
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Figure 4: Intersection of HIV and maternal mortality in Zimbabwe, 2008. Source: http://www.who.int/gho/maternal health/mortality/
maternal/en/index.html.
deaths in the sub-Saharan region, where the affected fraction
is between 9–32%. Country rankings between models are
similar and provide a general but not precise estimate of the
HIV epidemic’s contribution to maternal mortality.
More detailed examination at country level of the impact
of HIV on maternal and pregnancy-related deaths shows
diverse patterns. National estimates are usually based on few
data points and are subject to all the caveats mentioned
earlier about the identification of pregnancy-related deaths
and the classification of cause of death. Nonetheless, they give
an idea of the severe adverse effect of the HIV epidemic on
women’s health in high-burden countries.
5. Conclusions
Despite methodological challenges, assessments of trends in
maternal mortality clearly indicate that HIV has become a
leading cause of death during pregnancy and the postpartum
period in countries with high HIV prevalence and that
the HIV epidemic has slowed down progress in improving
maternal health.
Improved knowledge of the contribution of HIV to ma-
ternal and pregnancy-related mortality should help to direct
scarce resources to appropriate policy and programmatic
responses and spur better collaboration between HIV and
reproductive health services [1, 17]. We hope that our
examination of different approaches used to assess the inter-
actions between HIV and maternal mortality will stimulate
improvements in systems to document maternal deaths and
assess their causes.
It would be useful to distinguish between maternal HIV-
associated death due to direct obstetric causes or indirect
HIV-related causes and incidental pregnancy-related HIV
deaths. The new ICD-10 amendment introducing a new
code for an “indirect maternal death” is a step forward.
However, this is likely to continue to remain a source
of misclassification, given the ongoing clinical uncertainty
around the relationship between HIV and other causes of
maternal death. Further discussion among experts in ICD-
compliant death certification and coding is needed to help
clarify how best such interrelated causes of deaths should
be classified. Adoption of a common terminology among
researchers and health service providers would be a further
benefit.
There is also an urgent need to carry out systematic
reviews of existing studies on the key parameters that un-
derpin the estimates. These include studies on the relative
risk of maternal death in HIV-infected versus uninfected
pregnant women and the relative risk of dying from HIV
disease of a pregnant versus a nonpregnant woman. More
studies are also needed to elucidate the mechanisms by which
HIV can contribute to direct or indirect maternal deaths.
Nonetheless, given the close, almost inextricable inter-
actions between HIV and other causes of death during
and around pregnancy and inadequate systems for civil
registration in most countries, it will remain difficult to
quantify the precise impact of HIV on maternal mortality
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in the foreseeable future. This should not serve as an excuse
for inaction. Urgent measures are required to provide the
many girls and young women who face the dual risks of
HIV infection and pregnancy with the services that they
need. In settings with a high HIV burden and continuing
high maternal mortality ratios, especially in sub-Saharan
Africa, this means scaling up comprehensive and integrated
programmes that include both improved HIV treatment and
care and improved reproductive health services [9].
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